Droplet IV
Droplet IV is a Danish medical device company dedicated to developing a safe, simple, and cost-effective automatic IV line flushing solution. Their mission is to improve patient outcomes, reduce nurses' workload, and eliminate unnecessary medical waste by automating IV infusion therapy. The company is currently under development and aims to launch its first product in 2026, with a focus on enhancing healthcare sustainability and medication delivery accuracy.
Industries
Nr. of Employees
small (1-50)
Droplet IV
Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark
Patents
Flushing apparatus for use with an IV infusion set and an IV infusion set having an automatic flushing function
US-12208234-B2
View Details
Flushing apparatus for use with an IV infusion set and an IV infusion set having an automatic flushing function
US-12208234-B2
View DetailsProducts
Automated IV-line flushing device (prefilled, single-use)
A sterile, prefilled, single-use device that passively and automatically flushes IV lines when the medication bag is emptied. The device is designed without electronics and integrates with existing IV bags and lines to deliver residual medication trapped in infusion sets.
Automated IV-line flushing device (prefilled, single-use)
A sterile, prefilled, single-use device that passively and automatically flushes IV lines when the medication bag is emptied. The device is designed without electronics and integrates with existing IV bags and lines to deliver residual medication trapped in infusion sets.
Services
On-request demonstrations and clinical pilot engagement to evaluate device fit in clinical workflows and collect usability or outcome data.
On-request demonstrations and clinical pilot engagement to evaluate device fit in clinical workflows and collect usability or outcome data.
Expertise Areas
- IV infusion device development
- Medical device regulatory compliance (ISO 13485, FDA pathways)
- Human factors and clinical workflow integration
- Sterile single-use medical device design and manufacturing
Key Technologies
- Passive fluid-dynamics-based flushing mechanism
- Prefilled sterile single-use device
- Mechanical integration with standard IV bags and lines
- Design control and R&D documentation practices
News & Updates
Droplet IV completed a $2 million funding round to enable the launch of its automatic IV-line flushing device in the EU and US markets, aiming for a product launch in 2026.
Droplet IV received ISO 13485 certification, marking a major milestone towards market entry and demonstrating commitment to high-quality processes for medical devices.
Droplet IV announced leadership changes, including appointing Henriette Kirkegaard as Chairperson and Marcus Bech as CEO, to accelerate its go-to-market efforts and prepare for product launch in 2026.
Droplet IV won the Danish Tech Challenge, a significant recognition in the tech startup community.
Droplet IV received the Life Science Award in 2022, acknowledging its innovation in the medical field.
Droplet IV completed a $2 million funding round to enable the launch of its automatic IV-line flushing device in the EU and US markets, aiming for a product launch in 2026.
Droplet IV received ISO 13485 certification, marking a major milestone towards market entry and demonstrating commitment to high-quality processes for medical devices.
Droplet IV announced leadership changes, including appointing Henriette Kirkegaard as Chairperson and Marcus Bech as CEO, to accelerate its go-to-market efforts and prepare for product launch in 2026.
Droplet IV won the Danish Tech Challenge, a significant recognition in the tech startup community.
Droplet IV received the Life Science Award in 2022, acknowledging its innovation in the medical field.